A large Israeli study confirms that, among patients with ovarian cancer, carrying the BRCA1/2 mutation confers a survival advantage. Medscape Medical News
At 2-year follow-up, dasatinib continued to demonstrate efficacy and prolong survival among patients with chronic myelogenous leukemia who are either intolerant or resistant to treatment with imatinib. Medscape Medical News
Results from a phase 3 trial showed no improvement in disease-free survival with cisplatin, and a significantly worse colostomy rate. Medscape Medical News
The authors provide an overview on the biological markers that can play a role in early bladder cancer detection and can perhaps subsequently reduce the need for frequent cystoscopies. Expert Review of Molecular Diagnostics
Five genetic risk markers might help identify men at the highest risk for a diagnosis of prostate cancer and help tailor and individualize screening. Medscape Medical News
